Back to top

Weakness Seen in Relypsa (RLYP): Stock Plunges 19.3%
March 27, 2014

Read MoreHide Full Article
Relypsa, Inc. saw a big move in the last trading session, as the company’s shares fell by over 19% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $36.37 to $46.05 in the past one-month time frame.

This slump shouldn’t be too much of a surprise to investors, as the company, a pharmaceutical firm specializing in non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases, has seen 3 negative revisions in the past few weeks and its current year earnings consensus has also moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

RLYP currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Medical- Generic Drugs industry may consider better-ranked stocks like Dr. Reddy's Laboratories Ltd. (RDY - Free Report) , Mallinckrodt plc (MNK - Free Report) and Actavis plc . While Dr. Reddy’s and Mallinckrodt hold a Zacks Rank #1 (Strong Buy), Actavis carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Mallinckrodt PLC (MNK) - free report >>

Dr. Reddy's Laboratories Ltd (RDY) - free report >>

More from Zacks Tale of the Tape

You May Like